SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-06-22 17:11
Tx date 2023-06-19
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$143,880
+33,000 vol
$4.36 each
104,197
Filed 2023-06-22 17:09
Tx date 2023-06-19
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$347,750
+25,000 vol
$13.91 each
71,197
Filed 2023-06-22 17:08
Tx date 2023-06-19
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$120,996
+27,777 vol
$4.36 each
46,197
Filed 2023-06-22 17:07
Tx date 2023-06-19
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-143,880
-33,000 vol
$4.36 each
152,334
Filed 2023-06-22 17:06
Tx date 2023-06-19
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-347,750
-25,000 vol
$13.91 each
185,334
Filed 2023-06-22 17:05
Tx date 2023-06-19
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-120,996.612
-27,777 vol
$4.36 each
210,334
Filed 2023-03-23 21:08
Tx date 2023-03-21
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+24,000 vol
238,111
Filed 2022-06-02 13:11
Tx date 2022-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$53,996
+5,228 vol
$10.33 each
60,959
Filed 2022-02-25 22:27
Tx date 2022-02-23
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+45,000 vol
214,111
Filed 2021-06-01 17:06
Tx date 2021-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$63,002
+13,615 vol
$4.63 each
55,731
Filed 2021-03-01 19:22
Tx date 2021-02-25
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+33,000 vol
169,111
Filed 2020-06-12 17:33
Tx date 2020-06-10
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$51,034
+3,800 vol
$13.43 each
18,420
Filed 2020-06-02 19:51
Tx date 2020-06-01
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$131,100
+10,000 vol
$13.11 each
35,000
Filed 2020-06-01 16:59
Tx date 2020-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$72,004
+4,960 vol
$14.52 each
42,116
Filed 2020-04-01 18:06
Tx date 2020-04-01
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
136,111
Filed 2020-01-14 15:11
Tx date 2020-01-13
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
25,000
Filed 2020-01-14 15:07
Tx date 2020-01-13
$XENE
Xenon Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-20 17:00
Tx date 2019-08-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-288,889 vol
111,111
Filed 2019-08-20 16:59
Tx date 2019-08-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
37 - Stock split or consolidation

-96,604 vol
37,156
Filed 2019-08-20 16:58
Tx date 2019-08-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-38,012 vol
14,620
Filed 2019-05-31 14:28
Tx date 2019-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$45,000
+30,858 vol
$1.46 each
133,760
Filed 2019-04-22 10:15
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
59 - Exercise for cash

-1,657,757 vol
0
Filed 2019-04-22 10:14
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$-20,351,350
-814,054 vol
$25.00 each
0
Filed 2019-04-10 12:20
Tx date 2019-04-09
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership

+814,054 vol
814,054
Filed 2019-04-10 12:20
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-10 12:19
Tx date 2019-04-09
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-814,054 vol
0
Filed 2019-02-21
Tx date 2019-02-20
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
400,000
Filed 2019-02-21
Tx date 2019-02-18
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+463,300 vol
1,657,757
Filed 2018-12-18
Tx date 2018-12-18
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$50,000
+52,632 vol
$0.95 each
52,632
Filed 2018-12-18
Tx date 2017-09-27
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-05-31
Tx date 2018-05-31
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$45,000
+78,603 vol
$0.57 each
102,902
Filed 2018-04-20
Tx date 2018-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
1,194,457
Filed 2018-03-16
Tx date 2018-03-15
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
56 - Grant of rights
$11,250
+24,299 vol
$0.463 each
24,299
Filed 2018-03-16
Tx date 2017-09-27
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2018-02-27
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+305,000 vol
1,094,457
Filed 2018-02-23
Tx date 2018-02-20
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
300,000
Filed 2017-11-09
Tx date 2017-09-27
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-09
Tx date 2017-11-07
$BLU
BELLUS Health Inc.
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
150,000
Filed 2017-08-22
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
789,457
Filed 2017-08-22
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
814,054